It was a significant deal for wodgina, their sp is still struggling to push sh1t up hill, I expect similar deals with GXY will have the same result.
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress